ROYAL BANK OF CANADA - ACTINIUM PHARMACEUTICALS INC ownership

ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 38 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ACTINIUM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$49,0000.0%8,448
+25.5%
0.00%
Q2 2023$49,000
+6.5%
6,734
+38.5%
0.00%
Q1 2023$46,000
+58.6%
4,863
+82.6%
0.00%
Q4 2022$29,0002,663
+4571.9%
0.00%
Q3 2022$0
-100.0%
57
-86.0%
0.00%
Q1 2022$2,000406
+6666.7%
0.00%
Q4 2021$060.0%0.00%
Q3 2021$060.0%0.00%
Q2 2021$060.0%0.00%
Q1 2021$060.0%0.00%
Q4 2020$060.0%0.00%
Q3 2020$060.00%
Other shareholders
ACTINIUM PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Corton Capital Inc. 13,966$103,0000.13%
Delphia (USA) Inc. 14,226$105,0000.12%
Sentinus, LLC 22,500$166,0000.10%
Intrepid Financial Planning Group LLC 20,000$148,0000.08%
PERRITT CAPITAL MANAGEMENT INC 12,000$89,0000.06%
J. Goldman & Co LP 148,738$1,098,0000.05%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 88,966$657,0000.02%
EMFO, LLC 1,666$12,0000.01%
Virtu Financial LLC 12,590$93,0000.01%
Jump Financial, LLC 23,400$173,0000.01%
View complete list of ACTINIUM PHARMACEUTICALS INC shareholders